Ads
    Related paper
  1. Addition of Metformin to Liraglutide, A GLP-1 Receptor Agonist, Improves Glycemic Control in Patients with Type 2 Diabetes Mellitus
  2. The impact of three combinations vildagliptin/metformin, vildagliptin/pioglitazone, and metformin/pioglitazone on glycemic control and atherogenic dyslipidemia in patients with Type 2 diabetes mellitus
  3. DAMAGE OF RENAL FUNCTION AND DYNAMICS OF DYSLIPIDEMIA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH INSUFFICIENT GLYCEMIC COMPENSATION UNDER CONDITION OF CORRECTION OF HYPERTENSION WITH ANGIOTENSIN II RECEPTOR ANTAGONISTS
  4. The Relation of Glycemic Control and Primary Hypothyroidism in Saudi Patients with Type 2 Diabetes Mellitus
  5. Definition of the dependence of QTc interval prolongation on glycemic control in patients with type 2 diabetes mellitus
  6. Dynamics of endothelial dysfunction, nephropathic and dyslipidemic disorders in patients with insufficient glycemic compensation of type 2 diabetes mellitus during 1 year of application of angiotensin II receptor antagonists for hypertension correction
  7. STUDY OF COAGULATION PROFILE IN TYPE 2 DIABETES MELLITUS PATIENTS IN CORRELATION WITH LONG TERM GLYCEMIC CONTROL (HBA1C)
  8. Evaluate the Efficacy of Metformin and Glimepiride with Metformin in Patients with Type II Diabetes Mellitus
  9. Glycemic Control, Medication Use and Obesity among Patients with Type 2 Diabetes Mellitus Presenting to an Endocrinology Clinic during the War in Yemen. A Three-Year Retrospective Study
  10. Factors influencing sleep quality and its impact on glycemic control in patients with type II diabetes mellitus - A hospital based cross sectional study